Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway

Michiko Shimada1, Takuji Ishimoto, Pui Y Lee

  • 1Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA. mshimada@cc.hirosaki-u.ac.jp

Insights

Toll-like receptor 3 (TLR3) activation in human podocytes induces CD80 expression, a key factor in minimal-change disease (MCD) proteinuria. This pathway, dependent on nuclear factor kappa B (NF-κB), is partially inhibited by dexamethasone.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • CD80 (B7.1) is expressed on podocytes in minimal-change disease (MCD), potentially mediating proteinuria.
  • Toll-like receptor (TLR) ligands, known to induce CD80 on dendritic cells, were investigated for similar effects on podocytes.

Purpose of the Study:

  • To evaluate the ability of Toll-like receptors (TLRs) to induce CD80 expression in cultured human podocytes.
  • To elucidate the signaling pathway and potential therapeutic interventions for TLR-induced podocyte injury.

Main Methods:

  • Cultured human podocytes were assessed for TLR expression.
  • Polyinosinic-polycytidylic acid (polyIC), a TLR3 ligand, was used to stimulate CD80 expression.
  • Effects on Cathepsin L, synaptopodin, actin cytoskeleton, and signaling pathways (NF-κB, interferon) were analyzed.
  • CD80 knockdown and treatment with dexamethasone or NF-κB inhibitors were performed.

Main Results:

  • Podocytes express TLR1-6 and 9 mRNA.
  • PolyIC and lipopolysaccharide significantly induced CD80 mRNA expression, with polyIC showing the strongest effect.
  • PolyIC induced podocyte injury markers (increased Cathepsin L, decreased synaptopodin, actin reorganization) and activated NF-κB and interferon signaling.
  • CD80 knockdown mitigated polyIC-induced podocyte changes.
  • Dexamethasone and NF-κB inhibition reduced CD80 expression.

Conclusions:

  • TLR3 activation in human podocytes induces CD80 expression and phenotypic changes via an NF-κB-dependent mechanism.
  • Dexamethasone partially blocks this pathway, suggesting a link between viral infections, TLR activation, and proteinuria in MCD.
  • These findings offer insights into the pathogenesis of proteinuria in viral-associated kidney diseases.
Abstract

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...